XML 43 R28.htm IDEA: XBRL DOCUMENT
v3.25.1

COLLABORATION AND LICENSING AGREEMENTS (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
Collaboration and Licensing Agreements |
Schedule of Revenue | Disaggregation of total revenues by nature is as follows:
| Three Months Ended March 31, |  |
(in thousands) | 2025 |  | 2024 |  |  |  |
Product sales, net | $ | 67,814 |  |  | $ | 43,512 |  |  |  |  |
Licensing revenue | 5,020 |  |  | 17 |  |  |  |  |
Non-cash royalty revenue related to the sale of future royalties | 1,026 |  |  | 368 |  |  |  |  |
Product supply revenue | 254 |  |  | 2,126 |  |  |  |  |
Total revenues | $ | 74,114 |  |  | $ | 46,023 |  |  |  |  |
Total product sales, net was as follows:
| Three Months Ended March 31, |  |
(in thousands) | 2025 |  | 2024 |  |  |  |
Product sales, net |  |  |  |  |  |  |
IBSRELA | $ | 44,403 |  |  | $ | 28,361 |  |  |  |  |
XPHOZAH | 23,411 |  |  | 15,151 |  |  |  |  |
Total product sales, net | $ | 67,814 |  |  | $ | 43,512 |  |  |  |  |
The following table summarizes total revenues by collaboration partner:
| Three Months Ended March 31, |  |
(in thousands) | 2025 |  | 2024 |  |  |  |
Licensing revenue |  |  |  |  |  |  |
Fosun Pharma | $ | 5,000 |  |  | $ | — |  |  |  |  |
Knight | 20 |  |  | 17 |  |  |  |  |
Total licensing revenue | $ | 5,020 |  |  | $ | 17 |  |  |  |  |
Product supply revenue |  |  |  |  |  |  |
Kyowa Kirin | — |  |  | 2,126 |  |  |  |  |
Knight | 254 |  |  | — |  |  |  |  |
Total supply revenue | $ | 254 |  |  | $ | 2,126 |  |  |  |  |
Non-cash royalty revenue related to the sale of future royalties |  |  |  |  |  |  |
Kyowa Kirin | $ | 1,026 |  |  | $ | 368 |  |  |  |  |
Schedule of Deferred Revenue Balances | The following table presents changes in our current and non-current deferred revenue balances, which are all attributable to Kyowa Kirin:
| 2025 |  | 2024
(in thousands) | Current |  | Non-Current |  | Current |  | Non-Current
Deferred revenue balance as of January 1, | $ | 10,686 |  | $ | 7,232 |  | $ | 7,182 |  | $ | 8,644
Prepaid product supply | 227 |  | 1,118 |  | 732 |  | 3,459
Product supply delivered | — |  | — |  | (1,328) |  | —
Deferred revenue balance as of March 31, | $ | 10,913 |  | $ | 8,350 |  | $ | 6,586 |  | $ | 12,103

X
- Definition n/a + References No definition available. + Details
Name: | ardx_CollaborationAndLicensingAgreementsAbstract
Namespace Prefix: | ardx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration